Articles published by Genmab A/S
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
January 21, 2026
From Genmab A/S
Via GlobeNewswire
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
January 07, 2026
From Genmab A/S
Via Business Wire
Tickers
GMAB
Genmab Portfolio Prioritization Update
December 29, 2025
From Genmab A/S
Via Business Wire
Tickers
GMAB
Genmab Announces Financial Results for the Nine Months of 2025
November 06, 2025
From Genmab A/S
Via GlobeNewswire
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
November 03, 2025
From Genmab A/S
Via Business Wire
Tickers
GMAB
From Genmab A/S
Via GlobeNewswire
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
September 29, 2025
From Genmab A/S
Via Business Wire
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
September 29, 2025
From Genmab A/S
Via GlobeNewswire
Genmab Announces Financial Results for the First Half of 2025
August 07, 2025
From Genmab A/S
Via GlobeNewswire